The investment round was led by Angels in MedCity and Angel Academe.
Beamline Diagnostics
Beamline Diagnostics develops a rapid point-of-care biopsy screening system.
Beamline Diagnostics develops a rapid biopsy triaging system that screens tissue samples at the point of care. The technology aims to reduce unnecessary pathology lab workloads.
Filed accounts
Cash at bank
Net current assets
Total assets less current liabilities
Net assets
Shareholders' funds
Fixed assets
Cash, assets and headcount from Beamline Diagnostics's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team

Liberty Foreman
CEO
Liberty brings leadership experience across several medical and scientific organisations, having served as chief executive officer of DynamX Medical and AIRA Sciences. She currently holds roles at Beamline Diagnostics and AIRA Sciences.
Katherine Willetts
Katherine brings medical writing and founding experience, having previously worked at Oxford PharmaGenesis and co-founded DynamX Medical.
Ian Smith
Chairman